Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

NASDAQ:CHCI - Nasdaq - US2056842022 - Common Stock - Currency: USD

8.67  +0.4 (+4.84%)

Fundamental Rating

6

CHCI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. CHCI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHCI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

CHCI had positive earnings in the past year.
CHCI had a positive operating cash flow in the past year.
CHCI had positive earnings in each of the past 5 years.
Each year in the past 5 years CHCI had a positive operating cash flow.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

With an excellent Return On Assets value of 11.70%, CHCI belongs to the best of the industry, outperforming 98.31% of the companies in the same industry.
The Return On Equity of CHCI (14.64%) is better than 94.92% of its industry peers.
CHCI has a better Return On Invested Capital (13.39%) than 98.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHCI is significantly above the industry average of 4.84%.
The 3 year average ROIC (17.96%) for CHCI is well above the current ROIC(13.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROIC 13.39%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

CHCI's Profit Margin of 13.44% is amongst the best of the industry. CHCI outperforms 84.75% of its industry peers.
CHCI's Profit Margin has improved in the last couple of years.
The Operating Margin of CHCI (15.74%) is better than 83.05% of its industry peers.
CHCI's Operating Margin has improved in the last couple of years.
CHCI's Gross Margin of 21.03% is on the low side compared to the rest of the industry. CHCI is outperformed by 61.02% of its industry peers.
In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

CHCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CHCI has been increased compared to 1 year ago.
The number of shares outstanding for CHCI has been increased compared to 5 years ago.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

CHCI has an Altman-Z score of 2.20. This is not the best score and indicates that CHCI is in the grey zone with still only limited risk for bankruptcy at the moment.
CHCI's Altman-Z score of 2.20 is fine compared to the rest of the industry. CHCI outperforms 62.71% of its industry peers.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.2
ROIC/WACC1.44
WACC9.27%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.88 indicates that CHCI has no problem at all paying its short term obligations.
CHCI's Current ratio of 2.88 is fine compared to the rest of the industry. CHCI outperforms 69.49% of its industry peers.
CHCI has a Quick Ratio of 2.88. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
CHCI has a better Quick ratio (2.88) than 74.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 2.88
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CHCI have decreased strongly by -16.19% in the last year.
Measured over the past years, CHCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.50% on average per year.
CHCI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
The Revenue has been growing by 22.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.19%
EPS 3Y45.5%
EPS 5YN/A
EPS Q2Q%-49.97%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Sales Q2Q%-10.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CHCI Yearly EPS VS EstimatesCHCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.45, the valuation of CHCI can be described as correct.
Based on the Price/Earnings ratio, CHCI is valued cheaper than 84.75% of the companies in the same industry.
CHCI is valuated rather cheaply when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.45
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHCI is valued cheaper than 96.61% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHCI is valued cheaper than 96.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.11
EV/EBITDA 8.23
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

CHCI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (1/27/2025, 11:59:05 AM)

8.67

+0.4 (+4.84%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-19 2025-03-19
Inst Owners7.53%
Inst Owner Change0%
Ins Owners65.51%
Ins Owner Change1.17%
Market Cap85.75M
Analysts0
Price TargetN/A
Short Float %0.55%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.45
Fwd PE N/A
P/S 1.89
P/FCF 7.11
P/OCF 6.97
P/B 2.06
P/tB 2.06
EV/EBITDA 8.23
EPS(TTM)0.6
EY6.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.22
FCFY14.06%
OCF(TTM)1.24
OCFY14.35%
SpS4.59
BVpS4.22
TBVpS4.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.7%
ROE 14.64%
ROCE 16.95%
ROIC 13.39%
ROICexc 26.75%
ROICexgc 26.96%
OM 15.74%
PM (TTM) 13.44%
GM 21.03%
FCFM 26.55%
ROA(3y)22.97%
ROA(5y)16.15%
ROE(3y)35.73%
ROE(5y)27.33%
ROIC(3y)17.96%
ROIC(5y)15.67%
ROICexc(3y)33.58%
ROICexc(5y)27.55%
ROICexgc(3y)33.78%
ROICexgc(5y)29.13%
ROCE(3y)22.73%
ROCE(5y)21.64%
ROICexcg growth 3Y14.48%
ROICexcg growth 5Y117.95%
ROICexc growth 3Y21.59%
ROICexc growth 5Y120.25%
OM growth 3Y19.53%
OM growth 5Y62.13%
PM growth 3Y23.09%
PM growth 5YN/A
GM growth 3Y13.68%
GM growth 5Y31.25%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 109.57%
Cap/Sales 0.56%
Interest Coverage 250
Cash Conversion 166.82%
Profit Quality 197.54%
Current Ratio 2.88
Quick Ratio 2.88
Altman-Z 2.2
F-Score5
WACC9.27%
ROIC/WACC1.44
Cap/Depr(3y)205.5%
Cap/Depr(5y)183.3%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.79%
Profit Quality(3y)82.72%
Profit Quality(5y)263.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.19%
EPS 3Y45.5%
EPS 5YN/A
EPS Q2Q%-49.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.34%
Revenue growth 3Y25.73%
Revenue growth 5Y22.22%
Sales Q2Q%-10.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.77%
EBIT growth 3Y50.28%
EBIT growth 5Y98.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.29%
FCF growth 3Y38.44%
FCF growth 5Y-7.46%
OCF growth 1Y95.37%
OCF growth 3Y38.35%
OCF growth 5Y-6.94%